American Company To Offer Dog Cloning Service At International Public Auction
Main Category: VeterinaryAlso Included In: Biology / Biochemistry
Article Date: 23 May 2008 - 1:00 PDT
| Patient / Public: | ![]() |
4 (4 votes) |
| Healthcare Prof: | ![]() |
4 (3 votes) |
BioArts International (BioArts), announced that it will sell five dog cloning service slots to the general public via a worldwide, online auction to be held June 18th.
"We are thrilled to announce the Best Friends Again program," said CEO Lou Hawthorne. "This auction will give five very lucky people the ability to clone their family dogs. Given how challenging it is to clone dogs, this is a very rare and special offer."
The Best Friends Again website, http://www.bestfriendsagain.com, showcases three perfect clones of Hawthorne's beloved family dog "Missy", who died in 2002. Missy has been the subject of extensive cloning research since the "Missyplicity Project" began in 1997. "I can't decide which is more exciting: finally having three clones of Missy or being able to offer this amazing service to others," said Hawthorne.
BioArts has been granted the sole, worldwide license for the cloning of dogs, cats and endangered species. The license was granted by Start Licensing, Inc. and applies to the somatic cell nuclear transfer (SCNT) cloning patents developed at the Roslin Institute for the cloning of Dolly the sheep.
BioArts International is a new biotech startup focused on unique, untapped markets in the global companion animal, premium livestock and human genomics industries. The Best Friends Again program is a partnership between BioArts and the Sooam Biotech Research Foundation in South Korea, home to the best and most experienced dog cloning team in the world.
More information about the Best Friends Again program and the June 18th auction is available at http://www.bestfriendsagain.com.
BioArts International
Visit our veterinary section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/108490.php>
APA
http://www.medicalnewstoday.com/releases/108490.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



